ZEVALIN Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) - Congoo

|

|

News

Media & Advertising

ZEVALIN Receives Positive Reimbursement Ruling Using Average Sales Price (ASP)

Have an interest in this Story?
Sign Up for Real-Time email updates

SmartBrief | November 03, 2009

IRVINE, Calif.-- (BUSINESS WIRE) -- Spectrum Pharmaceuticals (NasdaqGM: SPPI), a commercial-stage biotechnology company with a primary focus in oncology, today announced that the Centers for Medicare & Medicaid Services (CMS) finalized a policy to allow reimbursement for ZEVALINÂ® (ibritumomab tiuxe...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

26 killed as ferry sinks in Indonesia - Gulf Times

Police suspect man killed in Beersheba car crash was murdered - Jerusalem Post

Iraq war files show US-UK tensions - Nuneaton News

Pricing Afghan troop buildup: $500,000 a soldier? - Chicago Tribune

Not Again! Huntingtown Residents Face Another Round Of Flooding - WUSA 9

Featured Members

David Hood
Director
Marketing/Public Relations

Niladri Roy
Manager-International Marketing
Computer Services

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2009 Congoo.com. All Rights Reserved.